Torre LA, Siegel RL, Ward EM, Jemal A. Global Cancer Incidence and Mortality Rates and Trends—An Update Global Cancer Rates and Trends—An Update. Cancer Epidemiol Biomarkers Prev. 2016; 25:16-27. https://doi.org/10.1158/1055-9965.EPI-15-0578.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71:209-249. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Li M, Zelchan R, Orlova A. The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer. Biomedicines. 2022;10(10), 2533. https://doi.org/10.3390/biomedicines10102533.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voter AF, Werner RA, Pienta KJ, et al. Piflufolastat F-18 (18F-DCFPyL) for PSMA PET imaging in prostate cancer. Expert Rev Anticancer Ther. 2022; 22:681-694. https://doi.org/10.1080/14737140.2022.2081155.

Article  CAS  PubMed  Google Scholar 

Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020; 395:1208-1216. https://doi.org/10.1016/S0140-6736(20)30314-7.

Article  CAS  PubMed  Google Scholar 

An S, Huang G, Liu J, Wei W. PSMA-targeted theranostics of solid tumors: applications beyond prostate cancers. Eur J Nucl Med Mol Imaging. 2022; 49:3973-3976. https://doi.org/10.1007/s00259-022-05905-7.

Article  PubMed  Google Scholar 

Werner RA, Habacha B, Lütje S, et al. High SUVs have more robust repeatability in patients with metastatic prostate cancer: Results from a prospective test-retest cohort imaged with 18F-DCFPyL. Mol Imaging. 2022; 2022:7056983. https://doi.org/10.1155/2022/7056983.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gafita A, Bieth M, Krönke M, et al. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT. J Nucl Med. 2019;60:1277-1283. https://doi.org/10.2967/jnumed.118.224055.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim M, Seifert R, Fragemann J, et al. Evaluation of thresholding methods for the quantification of [68Ga] Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy. Eur J Nucl Med Mol Imaging. 2023, 50(7), 2196–2209. https://doi.org/10.1007/s00259-023-06163-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karimi D, Dou H, Warfield SK, Gholipour A. Deep learning with noisy labels: Exploring techniques and remedies in medical image analysis. Med Image Anal. 2020; 65:101759. https://doi.org/10.1016/j.media.2020.101759.

Article  PubMed  PubMed Central  Google Scholar 

Budd S, Robinson EC, Kainz B. A survey on active learning and human-in-the-loop deep learning for medical image analysis. Med Image Anal. 2021; 71:102062. https://doi.org/10.1016/j.media.2021.102062.

Article  PubMed  Google Scholar 

Jin W, Li X, Fatehi M, Hamarneh G. Guidelines and evaluation of clinical explainable AI in medical image analysis. Med Image Anal. 2023; 84:102684. https://doi.org/10.1016/j.media.2022.102684.

Article  PubMed  Google Scholar 

Kshatri SS, Singh D. Convolutional Neural Network in Medical Image Analysis: A Review. Arch Comput Methods Eng. 2023; 30:2793-2810. https://doi.org/10.1007/s11831-023-09898-w.

Article  Google Scholar 

Salpea N, Tzouveli P, Kollias D. Medical Image Segmentation: A Review of Modern Architectures. In: Karlinsky, L., Michaeli, T., Nishino, K. (eds) Computer Vision – ECCV 2022 Workshops. ECCV 2022. Lecture Notes in Computer Science, vol 13807. Springer, Cham. https://doi.org/10.1007/978-3-031-25082-8_47.

Kendrick J, Francis R J, Hassan G M, et al. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga] Ga-PSMA-11 PET/CT images. Eur J Nucl Med Mol Imaging. 2020, 50(1), 67-79. https://doi.org/10.1007/s00259-022-05927-1.

Article  CAS  Google Scholar 

Sibille L, Seifert R, Avramovic N, et al. 18F-FDG PET/CT Uptake Classification in Lymphoma and Lung Cancer by Using Deep Convolutional Neural Networks. Radiology. 2020; 294:445-452. https://doi.org/10.1148/radiol.2019191114.

Article  PubMed  Google Scholar 

Yixi X, Ivan K, Sara H, et al. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss. Computers in Biology and Medicine. 2023;158:106882. https://doi.org/10.1016/j.compbiomed.2023.106882.

Lindgren Belal S, Frantz S, Minarik D, et al. Applications of Artificial Intelligence in PSMA PET/CT for Prostate Cancer Imaging. Semin Nucl Med. 2023;S0001-2998(23)00049-1. https://doi.org/10.1053/j.semnuclmed.2023.06.001.

Article  Google Scholar 

Mena E, Rowe SP, Shih JH, et al. Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy. J Nucl Med. 2022; 63:1184-1190. https://doi.org/10.2967/jnumed.121.262347.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Werner RA, Derlin T, Lapa C, et al. 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging. Theranostics. 2020; 10:1-16. https://doi.org/10.7150/thno.37894.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rowe SP, Buck A, Bundschuh RA, et al. [18F] DCFPyL PET/CT for imaging of prostate cancer. Nuklearmedizin. 2022; 61:240-246. https://doi.org/10.1055/a-1659-0010.

Article  PubMed  Google Scholar 

Yechiel Y, Orr Y, Gurevich K, Gill R, Keidar Z. Advanced PSMA-PET/CT Imaging Parameters in Newly Diagnosed Prostate Cancer Patients for Predicting Metastatic Disease. Cancers. 2023;15(4):1020. https://doi.org/10.3390/cancers15041020.

Vaswani A, Shazeer N, Parmar N, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30. https://doi.org/10.48550/arXiv.1706.03762.

Dosovitskiy A, Beyer L, Kolesnikov A, et al. An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale. arXiv preprint arXiv:11929 2020. https://doi.org/10.48550/arXiv.2010.11929.

Hatamizadeh A, Tang Y, Nath V, et al. UNETR: Transformers for 3D Medical Image Segmentation. Proceedings of the IEEE/CVF winter conference on applications of computer vision; 2022. p. 574-84. https://doi.org/10.48550/arXiv.2103.10504.

Schmidkonz C, Cordes M, Schmidt D, et al. 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. Eur J Nucl Med Mol Imaging. 2018; 45:1862-1872. https://doi.org/10.1007/s00259-018-4042-z.

Article  PubMed  Google Scholar 

Schmuck S, von Klot CA, Henkenberens C, et al. Initial experience with volumetric 68Ga-PSMA I&T PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with prostate cancer. J Nucl Med. 2017; 58:1962-1968. https://doi.org/10.2967/jnumed.117.193581.

Article  CAS  PubMed  Google Scholar 

Gul S, Khan MS, Bibi A, Khandakar A, Ayari MA, Chowdhury MEH. Deep learning techniques for liver and liver tumor segmentation: A review. Comput Biol Med. 2022; 147:105620. https://doi.org/10.1016/j.compbiomed.2022.105620.

Article  PubMed  Google Scholar 

Mohammed YMA, El Garouani S, Jellouli I. A survey of methods for brain tumor segmentation-based MRI images. Finite Elem Anal Des. 2023; 10:266-293. https://doi.org/10.1093/jcde/qwac141.

Article  Google Scholar 

Park J, Kang SK, Hwang D, et al. Automatic Lung Cancer Segmentation in [18F] FDG PET/CT Using a Two-Stage Deep Learning Approach. Nucl Med Mol Imaging. 2023; 57:86-93. https://doi.org/10.1007/s13139-022-00745-7.

Article  CAS  PubMed  Google Scholar 

Seifert R, Herrmann K, Kleesiek J, et al. Semiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer. J Nucl Med. 2020; 61(12):1786-1792. https://doi.org/10.2967/jnumed.120.242057.

Article  CAS  PubMed  Google Scholar 

Johnsson K, Brynolfsson J, Sahlstedt H, et al. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [18F] DCFPyL (PSMA) imaging for standardized reporting. Eur J Nucl Med Mol Imaging. 2022; 49:1041-1051. https://doi.org/10.1007/s00259-021-05497-8.

Article  PubMed  Google Scholar 

Nickols N, Anand A, Johnsson K, et al. aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer. J Nucl Med. 2022; 63:233-239. https://doi.org/10.2967/jnumed.120.261863.

Article  CAS  PubMed  Google Scholar 

Kendrick J, Francis RJ, Hassan GM. et al. Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga] Ga-PSMA-11 PET images. Eur J Nucl Med Mol Imaging. 2023;50:4077-86. https://doi.org/10.1007/s00259-023-06382-2.

36. Capobianco N, Sibille L, Chantadisai M, et al. Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning. Eur J Nucl Med Mol Imaging. 2022; 49:517-526. https://doi.org/10.1007/s00259-021-05473-2.

Article  CAS  PubMed  Google Scholar